NASDAQ:LTRN
Lantern Pharma Inc.
- Stock
Last Close
6.33
16/05 20:00
Market Cap
46.63M
Beta: 0.64
Volume Today
44.21K
Avg: 24.91K
PE Ratio
−3.14
PFCF: −3.29
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | -296K - | ||||||
average payables | 1.37M - | ||||||
average receivables | 296K - | ||||||
book value per share | -0.03 - | 0.15 567.44% | 4.58 2,916.16% | 6.56 43.43% | 5.16 21.31% | 3.77 26.94% | |
capex per share | -0.00 - | -0.00 307.67% | -0.00 62.08% | -0.00 80.55% | |||
capex to depreciation | -3.51 - | -4.76 35.55% | -2.29 51.87% | -2.76 20.49% | |||
capex to operating cash flow | 0.00 - | 0.00 6.28% | 0.00 48.75% | 0.00 49.03% | |||
capex to revenue | |||||||
cash per share | 0.07 - | 0.20 176.76% | 4.47 2,154.23% | 6.49 45.20% | 5.09 21.57% | 3.81 25.11% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | |||||||
debt to assets | 0.01 - | 0.00 48.00% | 0.90 32,368.29% | 0.01 99.40% | |||
debt to equity | 0.01 - | 0.00 48.01% | 0.94 32,892.92% | 0.01 99.39% | |||
dividend yield | |||||||
earnings yield | -0.02 - | -0.03 40.65% | -0.07 172.92% | -0.14 98.17% | -0.21 52.13% | -0.34 60.02% | |
enterprise value | 92.51M - | 91.72M 0.85% | 63.75M 30.50% | 35.70M 44.00% | 28.39M 20.48% | 24.70B 86,913.95% | |
enterprise value over ebitda | -53.58 - | -37.80 29.46% | -10.80 71.44% | -2.84 73.72% | -1.97 30.62% | -1.38 29.80% | |
ev to operating cash flow | -72.75 - | -43.10 40.75% | -11.28 73.83% | -3.37 70.12% | -2.22 34.04% | -1.72 22.56% | |
ev to sales | |||||||
free cash flow per share | -0.20 - | -0.34 67.80% | -1.32 283.66% | -0.97 26.12% | -1.18 21.23% | -1.32 12.21% | |
free cash flow yield | -0.01 - | -0.02 67.80% | -0.07 197.96% | -0.12 78.22% | -0.20 60.17% | -0.31 58.35% | |
graham net net | -0.03 - | 0.12 459.74% | 4.31 3,510.74% | 6.27 45.31% | 4.83 22.95% | 3.56 26.35% | |
graham number | 0.45 - | 1.15 156.41% | 11.89 929.54% | 12.90 8.55% | 12.28 4.81% | 11.18 8.98% | |
income quality | 0.74 - | 0.88 18.99% | 0.96 9.16% | 0.86 10.44% | 0.90 4.51% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -70.63 - | ||||||
interest debt per share | 0.03 - | 0.02 25.43% | 4.90 25,961.95% | 0.02 99.56% | |||
inventory turnover | |||||||
invested capital | 0.01 - | 0.00 48.01% | 0.94 32,892.92% | 0.01 99.39% | |||
market cap | 92.95M - | 92.95M 0% | 82.87M 10.85% | 87.02M 5.01% | 65.54M 24.69% | 46.41B 70,707.28% | |
net current asset value | -206.47K - | 743.53K 460.12% | 19.58M 2,532.87% | 70.34M 259.30% | 55.92M 20.49% | 40.60B 72,500.89% | |
net debt to ebitda | 0.26 - | 0.51 96.91% | 3.24 537.78% | 4.08 25.93% | 2.58 36.84% | 1.21 52.87% | |
net income per share | -0.28 - | -0.39 40.65% | -1.37 251.42% | -1.13 17.85% | -1.30 15.15% | -1.47 13.39% | |
operating cash flow per share | -0.20 - | -0.34 67.35% | -1.31 283.60% | -0.97 26.02% | -1.18 21.15% | -1.32 12.45% | |
payables turnover | |||||||
receivables turnover | |||||||
research and ddevelopement to revenue | |||||||
return on tangible assets | -3.84 - | -1.69 55.84% | -0.29 82.88% | -0.17 42.71% | -0.24 44.01% | -0.37 52.73% | |
revenue per share | |||||||
roe | 8.56 - | -2.57 130.09% | -0.30 88.35% | -0.17 42.72% | -0.25 46.33% | -0.39 55.21% | |
roic | 8.57 - | -2.57 130.04% | -0.30 88.41% | -0.17 41.68% | -0.13 24.83% | -0.43 230.41% | |
sales general and administrative to revenue | |||||||
shareholders equity per share | -0.03 - | 0.15 567.44% | 4.58 2,916.16% | 6.56 43.43% | 5.16 21.31% | 3.77 26.94% | |
stock based compensation to revenue | |||||||
tangible asset value | -201.80K - | 943.28K 567.44% | 19.70M 1,988.32% | 71.57M 263.33% | 56.04M 21.70% | 40.91B 72,900.31% | |
tangible book value per share | -0.03 - | 0.15 567.44% | 4.58 2,916.16% | 6.56 43.43% | 5.16 21.31% | 3.77 26.94% | |
working capital | -206.47K - | 743.53K 460.12% | 19.68M 2,547.46% | 70.39M 257.59% | 55.92M 20.55% | 40.66B 72,610.86% |
All numbers in USD (except ratios and percentages)